Product Categories
Country: | China |
---|---|
Tel: | 020-61855200 |
Mobile: | 18124244216 |
E-mail: | info@upharm.cn |
QQ: | 2885627074 |
Skype: | Chat Now! |
Address: | 12th floor, No. 181, Kexue Avenue, Huangpu District |
Tosun United Pharma and Group is committed to making due contributions to the cause of human health. At present, the group holds two wholly-owned subsidiaries: Guangzhou Tosun Pharmaceutical Co., Ltd. and Guangzhou Tosun-Bridge Pharm and Tech Ltd.
Guangzhou Tosun Pharmaceutical Co., Ltd.is a GSP (CRO) company that meets the requirements of modern management. It is the leader in the field of exporting and importing of APIs, excipients, prescriptions and impurities. In the past 20 years, the company has always adhered to the business philosophy of 'innovation, professional, integrity and self-discipline', and has a professional marketing team. Our sales network covering over 500 manufactures and work over 1000 products. With more than 1500 Clients from global market.
Tosun Pharma's main business covers from academic promotion and sales of preparations to sales and agents of preparations, APIs and chemical intermediates. It has the right of self import and export of the above products. At present, it acts as an agent for more than 30 imported raw materials, 30 agent preparations and more than 50 registration certificates of imported drugs being declared.
Guangzhou Juntai Medical Technology Co., Ltd. is a third-party technical service platform company under Tosun and United Pharmaceutical Group. It provides customers with professional one-stop solutions for pharmaceutical research and development, clinical pre BE and clinical BE. At present, the key businesses mainly include: API joint declaration, one-time import of reference preparation, clinical pre BE / formal BE and consistency evaluation service.
|
Product Name | MF | CAS | Details |
---|
Landiolol Impurity 7 | C25H39N3O8 | 144256-26-8 | Details |
Landiolol Impurity 4 | C19H29N3O6 | 190601-22-0 | Details |
Tamsulosin Impurity 21 | C9H14N2O3S.ClH | 622853-26-3 | Details |
Paliperidone Impurity 22 | Details |
Paliperidone Impurity 73 | Details |
Tamsulosin Impurity 2 | C20H28N2O5S | 116091-64-6 | Details |
Phenylephrine Impurity 13 | C13H17NO6 | 830346-80-0 | Details |
Tolvaptan Impurity 10 | C18H17ClN2O2 | 137977-97-0 | Details |
Norepinephrine Impurity 30 | C8H11NO3 | Details |
Lenvatinib Impurity 56 | C10H11ClN2O2 | 796848-79-8 | Details |
Lenvatinib Impurity 54 | C13H14N2O3 | 2143930-77-0 | Details |
Neratinib Impurity 14 | C26H22ClN5O3 | 915941-95-6 | Details |
Mycophenolate Mofetil EP Impurity D | C24H33NO7 | 1322681-37-7 | Details |
Methotrexate Impurity 39 | C22H26N8O5 | 65148-64-3 | Details |
Tetracaine(Oxybuprocaine)EP Impurity A(Benzocaine EP impurity G) | C7H7NO2 | 150-13-0 | Details |
Procaterol Impurity 4 | C16H20N2O3 | 63235-39-2 | Details |
Tolvaptan Impurity 5 | C26H23ClN2O3 | 137973-76-3 | Details |
Lomustine EP impurity C | C13H24N2O | 2387-23-7 | Details |
7-{4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butoxy}-1,2,3,4-tetrahydroquinolin-2-one hydrate | C23H29Cl2N3O3 | 851220-85-4 | Details |
Roxtidine Oxalate | C19H28N2O7 | 110925-92-3 | Details |
Osteltamivir Phosphate | C16H31N2O8P | 204255-11-8 | Details |
Loxoprofen Impurity 61 | C10H14O | 825-25-2 | Details |
Methotrexate Impurity 43 | C15H19N3O9 | 39925-10-5 | Details |
Ranolazine impurity 3 | 2731041-97-5 | Details |
3-N-Butylphthalide | C12H14O2 | 6066-49-5 | Details |
Mometasone Furoate Impurity L(Dexamethasone EP Impurity D) | C22H28O5 | 24916-90-3 | Details |
Lenvatinib Impurity 55 | C10H11NO2 | 97480-55-2 | Details |
Paliperidone Impurity 24 | Details |
Rifapentine impurity 6 | C4H12N4 | 106-59-2 | Details |
Urosodeoxycholic Acid Impurity 37 | Details |
Sitagliptin Impurity 18 | C6H7F3N4.ClH | 762240-92-6 | Details |
Lornoxicam Impurity 88 | Details |
Sitagliptin Impurity 13 | C16H12F6N4O2 | 764667-65-4 | Details |
Landiolol Impurity 8 | C7H15N3O2 | 69630-16-6 | Details |
Tamsulosin Impurity 1 | C10H14N2O4S | 944395-49-7 | Details |
2-(3-hydroxypropoxy)-1,25-dihydroxyvitamin D3 | C30H50O5 | 104121-92-8 | Details |
Methotrexate impurity 30 | C9H12N2O | 942840-87-1 | Details |
Lenvatinib Impurity 52 | C6H5Cl2NO | 50392-39-7 | Details |
Tamsulosin Impurity 6 | C20H28ClNO3 | 2724727-12-0 | Details |
Tamsulosin Impurity 26 | C19H24O4 | 420098-07-3 | Details |
Paliperidone Impurity 67 | C12H15ClN2O2 | 1160611-32-4 | Details |
Methotrexate Impurity 21 | C7H8Cl2N6 | 82778-08-3 | Details |
Salbutamol Impurity 21 | C13H17NO3 | 115787-52-5 | Details |
Paliperidone Impurity 75 | C12H13F2NO | 1016743-93-3 | Details |
Salbutamol Sulfate EP Impurity K | C13H18ClNO3 | 898542-80-8 | Details |
Rifapentine impurity 1 | C45H62N4O11 | 79039-56-8 | Details |
Salbutamol Impurity 03HCl | C13H22ClNO2 | 70334-18-8 | Details |
Paliperidone Impurity 74 | C24H27FN4O3 | 1204315-39-8 | Details |
Paliperidone Impurity 80 | Details |
Urosodeoxycholic Acid EP Impurity F(Obeticholic Acid Intermediate 1) | C24H38O4 | 4651-67-6 | Details |
Unknown impurity 3 (separation and purification) | Details |
Sitagliptin Impurity 14 | C16H13F6N5O | 767340-03-4 | Details |
Tamsulosin Impurity 20 | C17H22N2O3S.ClH | 622853-25-2 | Details |
4-Amino-5-chloro-N-(2-(diethylamino)ethyl)-2-methoxybenzamide | C14H22ClN3O2 | 364-62-5 | Details |
Norepinephrine Impurity 54 | C10H9BrO3 | 38396-89-3 | Details |
Sodium chloride designation | Details |
5-Methyl-2-phenyl-1,2-dihydropyrazol-3-one | C10H10N2O | 89-25-8 | Details |
N-desmethyl diltiazem hydrochloride (diltiazem impurity 17) | C21H24N2O4S | 86408-45-9 | Details |
Lysine impurity 4 | C10H18N2O4 | 499-86-5 | Details |
Lornoxicam Impurity 9 | C5H4ClNO4S2 | 1017791-22-8 | Details |
O-Desacetyl Diltiazem N-Oxide | C20H24N2O4S | 122619-90-3 | Details |
Allopregnanolone | C21H34O2 | 516-54-1 | Details |
Adefovir dipivoxil | C20H32N5O8P | 142340-99-6 | Details |
allyl chlorooxoacetate | C5H5ClO3 | 74503-07-4 | Details |
Alfacalcidol | C27H44O2 | 41294-56-8 | Details |
N,N-Dimethylformamide | C3H7NO | 68-12-2 | Details |
Mesalazine EP Impurity K | C6H7N | 62-53-3 | Details |
Altrenogest | C21H26O2 | 850-52-2 | Details |
Afatinib dimaleate | C28H29ClFN5O7 | 850140-73-7 | Details |
Posaconazole Impurity 229 | Details |
Trazodone Impurity 28 | C17H20ClN5O | 220910-12-3 | Details |
Pyronoprene Impurity 3 | C23H17N3O2 | 380919-34-6 | Details |
Levofolinate Impurity 14 | Details |
Arteparon | 63449-40-1 | Details |
Calcitriol | C27H44O3 | 32222-06-3 | Details |
Benoxinate Hydrochloride | C17H29ClN2O3 | 5987-82-6 | Details |
AZASETRON HYDROCHLORIDE | C17H21Cl2N3O3 | 141922-90-9 | Details |
Anastrozole | C17H19N5 | 120511-73-1 | Details |
Brinzolamide | C12H21N3O5S3 | 138890-62-7 | Details |
Bupivacaine Hydrochloride | C18H31ClN2O2 | 73360-54-0 | Details |
Calcipotriene | C27H40O3 | 112965-21-6 | Details |
Brexpiprazole | C25H27N3O2S | 913611-97-9 | Details |
Apraclonidine hydrochloride | C9H11Cl3N4 | 73218-79-8 | Details |
Zinc Gluconate | C12H22O14Zn | 4468-02-4 | Details |
afoxolaner | C26H17ClF9N3O3 | 1093861-60-9 | Details |
Aprepitant | C23H21F7N4O3 | 170729-80-3 | Details |
Brivaracetam | C11H20N2O2 | 357336-20-0 | Details |
Aripiprazole | C23H27Cl2N3O2 | 129722-12-9 | Details |
Bromfenac Sodium | C15H11BrNNaO3 | 120638-55-3 | Details |
Ammonium acetate | C2H7NO2 | 631-61-8 | Details |
Apalutamide | C21H15F4N5O2S | 956104-40-8 | Details |
BEPOTASTINE BESILATE | C27H31ClN2O6S | 190786-44-8 | Details |
Pyronoprene Impurity 24 | C22H16N2O | 380918-51-4 | Details |
Orciprenaline EP Impurity B | C11H15NO3 | 94200-14-3 | Details |
Paliperidone Impurity 71 | C23H28N4O4 | 1569268-43-4 | Details |
Paliperidone Impurity 46 | Details |
Paliperidone Impurity 70 | Details |
Paliperidone Impurity 81 | Details |
Phenylephrine Impurity 12 | C9H13NO2 | 2575516-52-6 | Details |
Benzenamine, 2,6-dichloro-4-[3-(1,1-dimethylethyl)-5-oxazolidinyl]-, hydrochloride (1:) | C13H19Cl3N2O | 50617-63-5 | Details |
Product Total: Product Page: | ||||
1 2 3 4 5 6 7 8 9 |